Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,565,651 papers from all fields of science
Search
Sign In
Create Free Account
Fetal Hemoglobin
Known as:
Hb F
, Hemoglobin F
, Fetal Hemoglobin [Chemical/Ingredient]
Expand
The major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
46 relations
Broader (2)
Fetal Proteins
Hemoglobin
Narrower (36)
Hemoglobin F-Albaicin
Hemoglobin F-Columbus-Ga
Hemoglobin F-Forest Park
Hemoglobin F-Hull
Expand
Hemoglobin F:PrThr:Pt:Bld:Ord:Alkali denat
Hemoglobin F:PrThr:Pt:Vomitus:Ord
Process of secretion
Second most predominant hemoglobin:Find:Pt:Bld.dot:Nom
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
C. Currie
,
J. Peters
,
+5 authors
C. Poole
The Lancet
2010
Corpus ID: 21223855
Highly Cited
2010
Highly Cited
2010
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
D. Bonds
,
Michael E. Miller
,
+14 authors
M. Sweeney
BMJ : British Medical Journal
2010
Corpus ID: 21904595
Objective To determine whether there is a link between hypoglycaemia and mortality among participants in the Action to Control…
Expand
Highly Cited
2009
Highly Cited
2009
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
P. Home
,
S. Pocock
,
+6 authors
J. McMurray
The Lancet
2009
Corpus ID: 25939495
Highly Cited
2009
Highly Cited
2009
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in…
M. Marre
,
J. Shaw
,
+6 authors
S. Colagiuri
Diabetic medicine : a journal of the British…
2009
Corpus ID: 16827344
Aim To compare the effects of combining liraglutide (0.6, 1.2 or 1.8 mg/day) or rosiglitazone 4 mg/day (all n ≥ 228) or placebo…
Expand
Highly Cited
2008
Highly Cited
2008
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
D. Drucker
,
J. Buse
,
+4 authors
L. Porter
The Lancet
2008
Corpus ID: 12667840
Review
2006
Review
2006
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis
P. Vestergaard
Osteoporosis International
2006
Corpus ID: 25201870
Introduction and hypothesisDiabetes affects bone metabolism. The hypothesis was that type 1 (T1D) and type 2 (T2D) affects BMD…
Expand
Highly Cited
2002
Highly Cited
2002
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study
M. Zander
,
S. Madsbad
,
J. Madsen
,
J. Holst
The Lancet
2002
Corpus ID: 27069372
Review
2002
Review
2002
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention
N. Unwin
,
J. Shaw
,
P. Zimmet
,
K. Alberti
Diabetic medicine : a journal of the British…
2002
Corpus ID: 38991233
Contents
Review
2001
Review
2001
Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
K. Khaw
,
N. Wareham
,
+4 authors
N. Day
BMJ : British Medical Journal
2001
Corpus ID: 10682841
Abstract Objective: To examine the value of glycated haemoglobin (HbA1c) concentration, a marker of blood glucose concentration…
Expand
Highly Cited
1984
Highly Cited
1984
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
O. Platt
,
S. Orkin
,
G. Dover
,
G. P. Beardsley
,
B. Miller
,
D. Nathan
The Journal of clinical investigation
1984
Corpus ID: 8133047
Hydroxyurea, a widely used cytotoxic/cytostatic agent that does not influence methylation of DNA bases, increases fetal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE